These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32505795)

  • 1. Electroporation-enhanced transdermal drug delivery: Effects of logP, pK
    Chen X; Zhu L; Li R; Pang L; Zhu S; Ma J; Du L; Jin Y
    Eur J Pharm Sci; 2020 Aug; 151():105410. PubMed ID: 32505795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical therapy for promoting transdermal delivery of topical formulations: Enhanced effect and underlying mechanism.
    Yang C; Peng X; Shi Y; Zhang Y; Feng M; Tian Y; Zhang J; Cen S; Li Z; Dai X; Jing Z; Shi X
    Int J Pharm; 2024 Mar; 652():123834. PubMed ID: 38262583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal drug delivery techniques: an extensive review of patents.
    Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration enhancement of transdermal delivery--current permutations and limitations.
    Purdon CH; Azzi CG; Zhang J; Smith EW; Maibach HI
    Crit Rev Ther Drug Carrier Syst; 2004; 21(2):97-132. PubMed ID: 15202928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of essential oil from Mentha haplocalyx and menthol used as penetration enhancers].
    Lan Y; Wang JY; Tao Y; Ru QG; Wang YF; Yu JX; Liu Y; Wu Q
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(8):1516-1522. PubMed ID: 28884549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids.
    Yi QF; Yan J; Tang SY; Huang H; Kang LY
    Drug Dev Ind Pharm; 2016; 42(7):1086-93. PubMed ID: 26635061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation: an avenue for transdermal drug delivery.
    Charoo NA; Rahman Z; Repka MA; Murthy SN
    Curr Drug Deliv; 2010 Apr; 7(2):125-36. PubMed ID: 20158490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of voltage gated transdermal drug delivery platform to impose synergistic enhancement in skin permeation using electroporation and gold nanoparticle.
    Anirudhan TS; Nair SS
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():437-446. PubMed ID: 31147014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
    Wong TW
    J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science of, and insights into, thermodynamic principles for dermal formulations.
    Tapfumaneyi P; Imran M; Alavi SE; Mohammed Y
    Drug Discov Today; 2023 Apr; 28(4):103521. PubMed ID: 36754143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants.
    Milewski M; Stinchcomb AL
    Mol Pharm; 2012 Jul; 9(7):2111-20. PubMed ID: 22702370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention.
    Tian Q; Quan P; Fang L; Xu H; Liu C
    Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.